• Something wrong with this record ?

Visual stimulation and brain-derived neurotrophic factor (BDNF) have protective effects in experimental autoimmune uveoretinitis

M. Zloh, P. Kutilek, J. Hejda, I. Fiserova, J. Kubovciak, M. Murakami, A. Stofkova

. 2024 ; 355 (-) : 122996. [pub] 20240820

Language English Country Netherlands

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24018700

AIMS: To investigate the therapeutic potential of visual stimulation (VS) and BDNF in murine experimental autoimmune uveoretinitis (EAU). MAIN METHODS: Mice were immunized by subcutaneous injection of interphotoreceptor retinoid-binding protein in Freund's complete adjuvant and intravenous injection of pertussis toxin, and were then exposed to high-contrast VS 12 h/day (days 1-14 post-immunization). EAU severity was assessed by examining clinical score, visual acuity, inflammatory markers, and immune cells in the retina. The transcriptome of activated retinal cells was determined by RNA-seq using RNA immunoprecipitated in complex with phosphorylated ribosomal protein S6. The retinal levels of protein products of relevant upregulated genes were quantified. The effect of BDNF on EAU was tested in unstimulated mice by its daily topical ocular administration (days 8-14 post-immunization). KEY FINDINGS: VS attenuated EAU development and decreased the expression of pro-inflammatory cytokines/chemokines and numbers of immune cells in the retina (n = 10-20 eyes/group for each analysis). In activated retinal cells of control mice (n = 30 eyes/group), VS upregulated genes encoding immunomodulatory neuropeptides, of which BDNF and vasoactive intestinal peptide (VIP) also showed increased mRNA and protein levels in the retina of VS-treated EAU mice (n = 6-10 eyes/group for each analysis). In unstimulated EAU mice, BDNF treatment mimicked the protective effects of VS by modulating the inflammatory and stem cell properties of Müller cells (n = 5 eyes/group for each analysis). SIGNIFICANCE: VS effectively suppresses EAU, at least through enhancing retinal levels of anti-inflammatory and neuroprotective factors, VIP and BDNF. Our findings also suggest BDNF as a promising therapeutic agent for uveitis treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018700
003      
CZ-PrNML
005      
20241024111222.0
007      
ta
008      
241015e20240820ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.lfs.2024.122996 $2 doi
035    __
$a (PubMed)39173995
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Zloh, Miloslav $u Department of Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Visual stimulation and brain-derived neurotrophic factor (BDNF) have protective effects in experimental autoimmune uveoretinitis / $c M. Zloh, P. Kutilek, J. Hejda, I. Fiserova, J. Kubovciak, M. Murakami, A. Stofkova
520    9_
$a AIMS: To investigate the therapeutic potential of visual stimulation (VS) and BDNF in murine experimental autoimmune uveoretinitis (EAU). MAIN METHODS: Mice were immunized by subcutaneous injection of interphotoreceptor retinoid-binding protein in Freund's complete adjuvant and intravenous injection of pertussis toxin, and were then exposed to high-contrast VS 12 h/day (days 1-14 post-immunization). EAU severity was assessed by examining clinical score, visual acuity, inflammatory markers, and immune cells in the retina. The transcriptome of activated retinal cells was determined by RNA-seq using RNA immunoprecipitated in complex with phosphorylated ribosomal protein S6. The retinal levels of protein products of relevant upregulated genes were quantified. The effect of BDNF on EAU was tested in unstimulated mice by its daily topical ocular administration (days 8-14 post-immunization). KEY FINDINGS: VS attenuated EAU development and decreased the expression of pro-inflammatory cytokines/chemokines and numbers of immune cells in the retina (n = 10-20 eyes/group for each analysis). In activated retinal cells of control mice (n = 30 eyes/group), VS upregulated genes encoding immunomodulatory neuropeptides, of which BDNF and vasoactive intestinal peptide (VIP) also showed increased mRNA and protein levels in the retina of VS-treated EAU mice (n = 6-10 eyes/group for each analysis). In unstimulated EAU mice, BDNF treatment mimicked the protective effects of VS by modulating the inflammatory and stem cell properties of Müller cells (n = 5 eyes/group for each analysis). SIGNIFICANCE: VS effectively suppresses EAU, at least through enhancing retinal levels of anti-inflammatory and neuroprotective factors, VIP and BDNF. Our findings also suggest BDNF as a promising therapeutic agent for uveitis treatment.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a mozkový neurotrofický faktor $x metabolismus $7 D019208
650    12
$a uveitida $x metabolismus $x farmakoterapie $x imunologie $7 D014605
650    12
$a retinitida $x farmakoterapie $x prevence a kontrola $x imunologie $7 D012173
650    12
$a autoimunitní nemoci $x imunologie $x metabolismus $7 D001327
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a retina $x metabolismus $x účinky léků $7 D012160
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a vazoaktivní intestinální peptid $x farmakologie $7 D014660
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a cytokiny $x metabolismus $7 D016207
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kutilek, Patrik $u Department of Health Care and Population Protection, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic
700    1_
$a Hejda, Jan $u Department of Health Care and Population Protection, Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic
700    1_
$a Fiserova, Ivana $u Department of Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kubovciak, Jan $u Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Murakami, Masaaki $u Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan; Group of Quantum Immunology, Institute for Quantum Life Science, National Institute for Quantum and Radiological Science and Technology (QST), Chiba, Japan; Division of Molecular Neuroimmunology, Department of Homeostatic Regulation, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi, Japan; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan
700    1_
$a Stofkova, Andrea $u Department of Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: andrea.stofkova@lf3.cuni.cz
773    0_
$w MED00003147 $t Life sciences $x 1879-0631 $g Roč. 355 (20240820), s. 122996
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39173995 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111216 $b ABA008
999    __
$a ok $b bmc $g 2201526 $s 1230673
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 355 $c - $d 122996 $e 20240820 $i 1879-0631 $m Life sciences $n Life Sci $x MED00003147
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Archiving options